Compare Kimberly Clark Corp (KMB) vs Lionsgate Studios Corp Common Shares (LION) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kimberly Clark Corp vs Lionsgate Studios Corp Common Shares — how do they compare? Kimberly Clark Corp trades at $102.5 (market cap $33.06B), while Lionsgate Studios Corp Common Shares trades at $10.89 (market cap $3.24B). The key difference: Kimberly Clark Corp is far larger — about 10.2× Lionsgate Studios Corp Common Shares's market cap, and Kimberly Clark Corp pays a 5.15% dividend while Lionsgate Studios Corp Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kimberly Clark Corp for 94 Days and Lionsgate Studios Corp Common Shares for 0 Days on average.
| KMB | LION | |
|---|---|---|
Market Cap | $33.06B | $3.24B |
Volume | 6,233,100 | 3,214,595 |
Sector | Consumer Staples | Technology |
52-Week High | $121.44 | $16.40 |
52-Week Low | $93.05 | $5.91 |
Typical Hold Time | 94 Days | 0 Days |
Enterprise Value | $38.62B | $6.75B |
Dividend Yield | 5.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kimberly-Clark (KMB) trades at $98.29, down 0.49% on the day, showing bearish technical momentum with the stock near key support levels. The company maintains solid profitability with 11.79% net margins and has beaten earnings estimates in 2 of the last 3 quarters. Recent executive transitions and the pending Kenvue acquisition create both opportunities and uncertainties for the consumer staples giant.
KMB offers a compelling 5.2% dividend yield with 54 consecutive years of increases, though cash flow sustainability remains a concern. Analyst consensus targets $117.25 (19% upside) but the stock faces headwinds from integration risks and competitive pressures in the personal care market.
LION trades at $11.12, up 0.36% on the day, with a market cap of approximately $1.3 billion. The stock shows mixed signals: strong analyst support (87.5% buy rating) and a consensus price target of $16.80 suggest upside, but negative net income and shareholder equity highlight financial strain. Recent Q1 2027 earnings beat estimates with EPS of $0.37, yet the company remains unprofitable with a net loss of $128.5 million in 2025. Takeover interest from firms like Bolloré adds speculative appeal.
The outlook hinges on operational turnaround and potential M&A. Revenue growth from hit films like 'Michael' and a valuable content library offer catalysts, but high debt ($3.65B total) and consistent losses pose significant risks. Investors should weigh the 51% upside to price targets against fundamental weaknesses and industry volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →About Lionsgate Studios Corp Common Shares
Lionsgate Studios Corp. is a standalone content company that develops, finances, produces, and distributes motion pictures and television series, licensing its content to theaters, streaming platforms, television networks, and home entertainment channels.
Read more on LION →
